Complete and send this form, together with applicable fee(s), by mail or fax, or via the USPTO patentelectronic filing system.
`
`PARTB - FEE(S) TRANSMITTAL
`
`By mail, sendto: Mail Stop ISSUE FEE By fax, send to:—(571)-273-2885
`
`Commissionerfor Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATIONFEE(if required). Blocks 1 through 5 should be completed where appropriate.
`All further correspondence will be mailed to the current correspondence address as indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new
`correspondenceaddress; and/or (b) indicating a separate "FEE ADDRESS"for maintenancefee notifications. Because electronic patent issuance may occur shortly after issue
`fee payment, any desired continuing application should preferably be filed prior to paymentof this issue fee in order not to jeopardize copendency.
`Note: A certificate of mailing can only be used for domestic mailings of the
`Fee(s) Transmittal. This certificate cannot be used for any other accompanying
`papers. Each additional paper, such as an assignment or formal drawing, must
`have its owncertificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEEaddress above,or being transmitted to the
`USPTOvia the USPTO patentelectronic filing system or by facsimile to (571)
`273-2885, on the date below.
`(Typed or printed name
`(Signature
`(Date
`
`CURRENT CORRESPONDENCE ADDRESS(Note: Use Block 1 for any change of address)
`
`07/01/2024
`7590
`28977
`Morgan, Lewis & Bockius LLP (PH)
`2222 MarketStreet
`Philadelphia, PA 19103
`
`
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATIONNO.
`
`Ge Wei
`12/19/2022
`18/068,418
`TITLE OF INVENTION: PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
`
`063995-01-5105-US 10
`
`5769
`
`
`
`
`
`
`
`APPLN. TYPE PUBLICATION FEE DUE|PREV. PAID ISSUE FEEENTITY STATUS ISSUE FEE DUE TOTAL FEE(S) DUE DATE DUE
`
`
`
`
`
`UNDISCOUNTED
`nonprovisional
`EXAMINER
`
`$1200
`ART UNIT
`
`$0.00
`CLASS-SUBCLASS
`
`$0.00
`
`$1200
`
`10/01/2024
`
`1656
`MCKNIGHT, CIARA A
`1. Change of correspondenceaddressor indication of "Fee Address” (37
`CFR 1.363).
`
`
`
`424-094620
`2. For printing on the patent front page,list
`
`(1) The namesof up to 3 registered patent attorneys
`, Morgan, Lewis & Bockius LLP
`or agents OR,alternatively,
`LJ Changeof correspondence address (or Change of Correspondence
`(2) The nameofa single firm (having as a member a
`Address form PTO/AIA/122 or PTO/SB/122)attached.
`registered attorney or agent) and the names of upto=2
`2 registered patent attorneys or agents. If no nameis
`(J "Fee Address"indication (or "Fee Address” Indication form PTO/
`listed, no namewill be printed.
`AIA/47 or PTO/SB/47; Rev 03-02 or more recent) attached. Use of a
`Customer Numberis required.
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT(printor type)
`PLEASE NOTE: Unlessan assigneeis identified below, no assignee data will appear on the patent. If an assigneeis identified below, the document must have been previously
`recorded,orfiled for recordation, as set forth in 37 CFR 3.11 and 37 CFR 3.81(a). Completion of this form is NOTa substitute forfiling an assignment.
`(A) NAMEOF ASSIGNEE
`(B) RESIDENCE:(CITY and STATE OR COUNTRY)
`Halozyme,Inc.
`San Diego, CA
`Please check the appropriate assignee category or categories (will not be printed on the patent) : () individual
`4a. Fees submitted:
`KUIssue Fee
`(LIpublication Fee (if required)
`4b. Method of Payment: (Please first reapply any previously paidfee shown above)
`(J Non-electronic paymentby credit card (Attach form PTO-2038)
`XK) Electronic Paymentvia the USPTOpatentelectronicfiling system
`(J Enclosed check
`The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any overpaymentto Deposit Account No. 50-0310
`
`Corporation or other private group entity (J Government
`
`5. Changein Entity Status (from status indicated above)
`NOTE:Absenta valid certification of Micro Entity Status (see forms PTO/SB/15A and 15B), issue
`fee paymentin the micro entity amountwill not be accepted at the risk of application abandonment.
`= Applicant certifying micro entity status. See 37 CFR 1.29
`NOTE:If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlementto micro entity status.
`im Applicant asserting small entity status. See 37 CFR 1.27
`NOTE:Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`LJ Applicant changing to regular undiscounted fee status.
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements andcertifications.
`
`Authorized Signature /Kalpesh V. Upadhye/
`Date August 16, 2024
`
`Typed or printed name Kalpesh V. Upadhye Ph.D.
`Registration No, 70.236
`
`PTOL-85 Part B (11/23) Approved for use through 03/31/2026
`
`Page 2 of 3
`OMB 0651-0033
`
`USS. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`